CH Biotech R&D Co., Ltd. announced CHB resignation of Brent Randall Smith as Natural-person director, effective March 2, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
86.8 TWD | +1.17% | -1.70% | +7.83% |
05-21 | Ch Biotech R&D Co., Ltd. Approves the Appointments of the 4th Remuneration Committee Members | CI |
05-21 | CH Biotech R&D Co., Ltd. Announces Audit Committee Changes | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.83% | 274M | |
+16.74% | 38.99B | |
-.--% | 11.36B | |
-3.33% | 7.61B | |
+1.10% | 6.45B | |
-4.79% | 6.01B | |
-4.50% | 5.73B | |
+32.88% | 5.25B | |
-16.30% | 5.23B | |
-13.40% | 4.58B |
- Stock Market
- Equities
- 6534 Stock
- News CH Biotech R&D Co., Ltd.
- CH Biotech R&D Co., Ltd. Announces CHB Resignation of Brent Randall Smith as Natural-Person Director